DDC Antikörper (AA 32-61)
Kurzübersicht für DDC Antikörper (AA 32-61) (ABIN7873933)
Target
Alle DDC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 32-61
-
Verwendungszweck
- AADC Antibody / DOPA Decarboxylase / DDC
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- A portion of amino acids 32-61 from the human protein was used as the immunogen for the AADC antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting points. Titration of the AADCantibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the AADC antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- DDC (Dopa Decarboxylase (Aromatic L-Amino Acid Decarboxylase) (DDC))
-
Andere Bezeichnung
- AADC
-
Hintergrund
- This protein catalyzes the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine, L-5-hydroxytryptophan to serotonin and L-tryptophan to tryptamine. Defects in this gene are the cause of aromatic L-amino-acid decarboxylase deficiency (AADCD). AADCD deficiency is an inborn error in neurotransmitter metabolism that leads to combined serotonin and catecholamine deficiency.
-
UniProt
- P20711
-
Pathways
- Dopaminergic Neurogenesis
Target
-